Skip to main content
Equibles

VOYA INVESTMENT MANAGEMENT LLC

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1068837 ATLANTA, GA
Back to AMRX Full portfolio

Position in AMRX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,939,255
+$2,614,012 QoQ
Shares Held
169,801
+548.9% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 311 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 19% None 81%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $134,224,123 across 32 Drug Manufacturers - Specialty & Generic names. AMRX ranks #12 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LNTH
Lantheus Holdings, Inc.
 370,571 $41,111,146
2 NBIX
Neurocrine Biosciences Inc
 113,293 $19,094,401
3 ELAN
Elanco Animal Health Inc
 442,383 $10,887,045
4 VTRS
Viatris Inc
 471,235 $7,483,211
5 UTHR
UNITED THERAPEUTICS Corp
 13,289 $7,200,378
6 ZTS
Zoetis Inc.
 89,660 $6,442,967
7 ALKS
Alkermes plc.
 118,998 $6,235,494
8 XERS
Xeris Biopharma Holdings, Inc.
 685,570 $5,429,713

All Filings in AMRX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,939,255 169,801
2026-03-31 $325,243 26,166
2025-12-31 $340,111 26,993
2025-09-30 $274,263 27,399
2025-06-30 $356,493 44,066
2025-03-31 $365,921 43,666
2024-09-30 $432,057 51,930
2024-06-30 $339,578 53,477
2024-03-31 $2,305,338 380,419
2023-12-31 $297,096 48,945
2023-09-30 $211,936 50,222
2023-06-30 $152,538 49,206
2023-03-31 $58,139 41,827
2022-12-31 $83,235 41,827
2022-09-30 $84,490 41,827
2022-06-30 $133,009 41,827
2022-03-31 $174,418 41,827
2021-12-31 $187,432 39,130
2021-09-30 $214,833 40,231
2021-06-30 $205,982 40,231
2021-03-31 $299,969 44,572
2020-12-31 $191,930 41,998
2020-09-30 $143,300 36,933
2020-06-30 $194,879 40,941
2020-03-31 $210,957 60,620